Dissolution Similarity Requirements: How Similar or Dissimilar Are the Global Regulatory Expectations?
Journal Title: The AAPS Journal - Year 2016, Vol 18, Issue 1
Abstract
The objective of this article is to compare and contrast the international expectations associated with the model-independent similarity factor approach to comparing dissolution profiles. This comparison highlights globally divergent regulatory requirements to meet local dissolution similarity requirements. In effect, experiments customized to meet the current international regulatory expectations for dissolution and drug release unnecessarily increase manufacturing costs, hinder science and risk-based approaches, increase collective regulatory burden, reduce continuous improvement and innovation, and potentially delay patient access to urgently needed medication. Comparative assessment of regulatory differences in applying dissolution to demonstrate product similarity is crucial to reduce non-scientifically justified experiments and foster collaborative harmonization among global regulatory health authorities and the pharmaceutical industry.
Authors and Affiliations
Dorys Argelia Diaz, Stephen T. Colgan, Connie S. Langer, Nagesh T. Bandi, Michael D. Likar, Leslie Van Alstine
Keywords
Related Articles
- EP ID EP680817
- DOI 10.1208/s12248-015-9830-9
- Views 48
- Downloads 0
Design and Evaluation of Thioalkylated Mannose-Modified Dendrimer (G3)/α-Cyclodextrin Conjugates as Antigen-Presenting Cell-Selective siRNA Carriers
The online version of this article (doi:10.1208/s12248-014-9665-9) contains supplementary material, which is available to authorized users.
Challenges in Development of Nanoparticle-Based Therapeutics
In recent years, nanotechnology has been increasingly applied to the area of drug development. Nanoparticle-based therapeutics can confer the ability to overcome biological barriers, effectively deliver hydrophobic drugs...
Application of Absorption Modeling in Rational Design of Drug Product Under Quality-by-Design Paradigm
Physiologically based absorption models can be an important tool in understanding product performance and hence implementation of Quality by Design (QbD) in drug product development. In this report, we show several case...
A Method to Evaluate Fetal Erythropoiesis from Postnatal Survival of Fetal RBCs
Fetal RBCs are produced during a period of very rapid growth and stimulated erythropoiesis under hypoxic intrauterine conditions. Fetal RBC life span varies with gestational age (GA) and is shorter than that in healthy a...
UGT1A1 polymorphism predicts irinotecan toxicity: Evolving proof